As from December 29th 2023, Chordate Medical Holding AB (publ) will change Certified Adviser to Vator Securities AB. This information is distributed at the request of the Certified Adviser, Västra hamnen Corporate Finance AB. For further information, please call Västra Hamnen Corporate Finance AB on +46 40 20 02 50.
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Chordate Medical's CEO looks ahead to 2025 - "The exit process is our primary focus" | ||
| 05.11. | Chordate Medical Holding AB: Chordate Medical Holding (publ) Interim Report January-September 2024 | Summary of the period July-September 2024Net turnover was SEK 147,993 (210,947)Cash flow from operating activities was SEK -5,126,552 (-4,325,051)Profit/loss after financial items was SEK -5,681,292... ► Artikel lesen | |
| 17.10. | Chordate Medical advances to final phase of exit strategy | ||
| 06.09. | CHORDATE MEDICAL: Promising results in Chordate's follow-up study | ||
| 03.09. | CHORDATE MEDICAL: Focus on market establisment for Chordate |
